Arizona Oncology Associates Pc
Hematology & Oncology
2625 N Craycroft Rd Ste 200b, Tucson
Arizona, 85712-2268
520-416-5744 602-476-5156
Arizona Oncology Associates Pc is an authorized DME supplier for medicare equipments and products.
Arizona Oncology Associates Pc is a Hematology & Oncology in Tucson, Arizona. It is located at 2625 N Craycroft Rd Ste 200b, Tucson and it's customer support contact number is 520-416-5744. The authorized person of Arizona Oncology Associates Pc is Lee Andrew Pendleton, PHARMD who is Manager Pharmacy Operations of the pharmacy and his contact number is 520-390-6189. Arizona Oncology Associates Pc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Arizona Oncology Associates Pc is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Pharmacy Details:
Arizona Oncology Associates Pc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Arizona Oncology Associates Pc |
| Type: | Hematology & Oncology |
| Location: | 2625 N Craycroft Rd Ste 200b, Tucson, Arizona, 85712-2268 |
| Phone: | 520-416-5744 |
| Fax: | 602-476-5156 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Lee Andrew Pendleton |
| Credentials: | PHARMD |
| Position: | Manager Pharmacy Operations |
| Contact Number: | 520-390-6189 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1578976379 |
| NPI Enumeration Date: | 09 Jun, 2014 |
| NPI Last Update On: | 03 Oct, 2023 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Arizona Oncology Associates Pc are as mentioned below.
| Specialization | License Number | State | Status | |
| Hematology & Oncology | | | Primary | |
| Non-pharmacy Dispensing Site | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 0359491 | Other | Arizona | Ncpdp |
| 289515 | Medicaid | Arizona | |
Medicare Enrollment:
Arizona Oncology Associates Pc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 9638067911 | O20150717002715 | Arizona Oncology Associates Pc | DME SUPPLIER - PHYSICIAN - HEMATOLOGY/ONCOLOGY |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 2625 N Craycroft Rd Ste 221, Tucson, Arizona |
| Zip: | 85712-2268 |
| Phone Number: | 520-390-6189 |
| Fax Number: | 520-519-7910 |
Patients can reach Arizona Oncology Associates Pc at
2625 N Craycroft Rd Ste 200b, Tucson, Arizona or can
call on customer care at 520-416-5744.
Comments/ Reviews:
Read all the reviews posted for Arizona Oncology Associates Pc below. You may also share your own experience with Arizona Oncology Associates Pc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.